Virus News and Research

Latest Virus News and Research

Alternative options could improve cervical cancer screening rate among transgender men, study shows

A new study indicates that alternative options for cervical cancer screening, including self-sampling for human papilloma virus (HPV) testing, could improve the screening rate among transgender men.

8 Sep 2017

Direct-acting antiviral therapy found to be safe, effective in patients with CKD and HCV infection

A new study indicates that direct-acting antiviral therapy is safe and effective in patients with chronic kidney disease (CKD) and Hepatitis C virus (HCV) infection.

8 Sep 2017

Combination treatment provides positive results for people with advanced melanoma

In a two-year UCLA-led study, nearly two-thirds of people with advanced melanoma responded positively to a treatment that combines the immunotherapy drug pembrolizumab with a herpes virus called talimogene laherpareovec, or T-VEC.

8 Sep 2017

Newest vaccine highly effective at preventing nine types of HPV infection, study shows

Cervical cancer is the second most common cause of cancer-related death worldwide, with almost 300,000 deaths occurring each year. More than 80 percent of these deaths occur in developing nations.

7 Sep 2017

Differentiating sepsis and systemic inflammatory response syndrome using biomarkers

Firstly, it is necessary to make a distinction between systemic inflammation and Systemic Inflammatory Response Syndrome (SIRS). SIRS consists of changes in clinical signs including an abnormal body temperature, increased heart rate, increased respiratory rate, an abnormal white cell count (either decreased or elevated), or an increase in band neutrophils.

7 Sep 2017

Bacteria in aquatic environment can modulate the ability of adult mosquitoes to transmit human pathogens

Mosquitoes are holometabolous insects (i.e. organisms that go through a complete metamorphosis). As such, they occupy two main habitats during their life cycle.

7 Sep 2017

Ten-foot living structure in Manchester helps launch HIV has Changed campaign today

A national HIV awareness campaign is launching today (Thursday 7 September) on New Cathedral Street, Manchester.

7 Sep 2017

Study finds long-term effectiveness of HPV vaccine in preventing cervical cancer

A vaccine that can literally eradicate the majority of cervical cancer cases shows long-term effectiveness in a study published today in The Lancet.

6 Sep 2017

New treatment protects nonhuman primates against Lassa fever eight days after infection

A collaborative team of scientists, led by a group at The University of Texas Medical Branch at Galveston, have successfully protected nonhuman primates against one of the most deadly viruses in the world, Lassa fever, eight days after they became infected.

6 Sep 2017

Zika virus found to specifically kill glioblastoma brain cancer cells

According to a latest study supported by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health, the deadly Zika virus could be used to kill a specific type of brain cancer cells and sparing the neighbouring healthy brain cells. Although experimental in stage, this finding has wide implications for those suffering from these cancers.

5 Sep 2017

Zika virus may one day be effective treatment for deadly brain cancer

While Zika virus causes devastating damage to the brains of developing fetuses, it one day may be an effective treatment for glioblastoma, a deadly form of brain cancer.

5 Sep 2017

Hepatitis A outbreak among population of San Diego

The San Diego population is facing one of the worst outbreaks of infective viral disease Hepatitis A. the outbreak began last November and is still going strong with no signs of reduction in the infection rates. The homeless are one of the worst hit.

3 Sep 2017

Researchers identify impact of climatic factors on dengue disease burden in India

The University of Liverpool is part of an international team of scientists that have identified the climatic risks for dengue disease outbreaks, with a new study undertaken in India.

1 Sep 2017

Viral RNAs make use of cell's transportation system, study finds

Flaviviruses are a significant threat to public health worldwide, and some infected patients develop severe -- potentially fatal -- neurological diseases.

1 Sep 2017

Researchers explore causal link between perirhinal neurons and mnemonic judgment of objects

Cognitive neuroscience research on non-human primates demonstrated that judgments of whether humans have previously seen or not seen an object are causally determined by neuronal signals generated in the temporal cortex of the brain. The findings are published in Science (August 2017).

1 Sep 2017

St. Kitts launches probe of herpes vaccine tests on U.S. patients

The government of St. Kitts and Nevis has launched an investigation into the clinical trial for a herpes vaccine by an American company because it said its officials were not notified about the experiments.

31 Aug 2017

Study finds virus that causes mononucleosis could raise risk of multiple sclerosis

Like whites, Hispanic and black people who have had mononucleosis, commonly known as mono, which is caused by Epstein-Barr virus, may have an increased risk of multiple sclerosis (MS), according to a new study published in the August 30, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology.

31 Aug 2017

Researcher uses gold nanoparticles and lasers to target bladder cancer

A University of Colorado Cancer Center study takes a new approach to killing cancer: Why not fry it into oblivion with vibrating gold nanoparticles? "But what about the frickin' lasers?" you may ask. Don't worry. There are lasers. And bioluminescence too.

31 Aug 2017

Experimental drug isolated from tick saliva may hold promise for reducing HIV-linked heart disease risk

Scientists may have found a clue to why people living with HIV have double the likelihood of developing heart disease.

30 Aug 2017

$Novartis gets FDA approval for novel immunocellular therapy to treat relapsed or refractory B-cell ALL$

Novartis gets FDA approval for novel immunocellular therapy to treat relapsed or refractory B-cell ALL

Novartis announced today that the US Food and Drug Administration has approved Kymriah (tisagenlecleucel) suspension for intravenous infusion, formerly CTL019, the first chimeric antigen receptor T cell (CAR-T) therapy, for the treatment of patients up to 25 years of age with B-cell precursor acute lymphoblastic leukemia (ALL) that is refractory or in second or later relapse.

30 Aug 2017

Virus News and Research

Latest Virus News and Research

Alternative options could improve cervical cancer screening rate among transgender men, study shows

Direct-acting antiviral therapy found to be safe, effective in patients with CKD and HCV infection

Combination treatment provides positive results for people with advanced melanoma

Newest vaccine highly effective at preventing nine types of HPV infection, study shows

Differentiating sepsis and systemic inflammatory response syndrome using biomarkers

Bacteria in aquatic environment can modulate the ability of adult mosquitoes to transmit human pathogens

Ten-foot living structure in Manchester helps launch HIV has Changed campaign today

Study finds long-term effectiveness of HPV vaccine in preventing cervical cancer

New treatment protects nonhuman primates against Lassa fever eight days after infection

Zika virus found to specifically kill glioblastoma brain cancer cells

Zika virus may one day be effective treatment for deadly brain cancer

Hepatitis A outbreak among population of San Diego

Researchers identify impact of climatic factors on dengue disease burden in India

Viral RNAs make use of cell's transportation system, study finds

Researchers explore causal link between perirhinal neurons and mnemonic judgment of objects

St. Kitts launches probe of herpes vaccine tests on U.S. patients

Study finds virus that causes mononucleosis could raise risk of multiple sclerosis

Researcher uses gold nanoparticles and lasers to target bladder cancer

Experimental drug isolated from tick saliva may hold promise for reducing HIV-linked heart disease risk

Novartis gets FDA approval for novel immunocellular therapy to treat relapsed or refractory B-cell ALL

A new way of characterising biomolecules eBook

CoppaFeel!: Breast Cancer Doesn’t Discriminate, So Why Should Awareness?

The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

CoppaFeel!: Breast Cancer Doesn’t Discriminate, So Why Should Awareness?

The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Newsletters you may be interested in